Health care reform is an entirely different thing from health care insurance. Health care would be much cheaper if there was no such thing as health care insurance. The purpose of Obamacare was not to provide health insurance. It was to destroy private health care. But the socialists ideas always produce scarcity and less quality in whatever they take over. True health care reform would involve applying basic economic principles , such as increasing the number of doctors and nurses, eliminating artificial restrictions to entry into the various medical fields, promoting charity hospitals, etc. Instead , we are presented with a fraudulent scheme designed to destroy the private health care industry, and to fleece the young and healthy, and whlich is continually lied about by Obama, and hls democrat socialist gang, who passed it . There purpose is to buy enough votes to establish a socialist/communist regime in the US so Obama can bring Americans down to the low level he thinks they deserve. Meanwhlile he, like all communist head of state, wiil be very wealtlhy.
UK Early Access to Medicines Scheme to launch in April
WORLD NEWS | MARCH 14, 2014
A pharmaceutical industry-funded Early Access to Medicines Scheme (EAMS) is to launch in the UK in April, offering severely-ill patients the opportunity to try ground-breaking new medicines “years” before they would normally reach them, Ministers have announced.
The Scheme will enable patients with life-threatening and seriously debilitating conditions to receive innovative and promising new drugs as soon as the Medicines and Healthcare products Regulatory Agency (MHRA) has signalled that the benefits outweigh the risks, through a two-stage evaluation process.
In stage one, if the MHRA considers a product to be a possible candidate for EAMS, it will issue a Promising Innovative Medicines (PIM) designation, based on early clinical data. In stage two, the Agency will issue an EAMS Scientific Opinion if the quality, safety and efficacy data provided in support of the application is sufficient to support a positive benefit/risk balance and added clinical value.
EAMS will be complemented by a new National Institute for Health and Care Excellence (NICE) technology appraisal and NHS England commissioning process.
elk is happy because ignorance is bliss. keep is always unhappy. It's his nature.
That's generally true, and sometimes I begin to feel a twinge of pity for the pathetic thing, but he's such a batshit crazy #$%$ I just can't bring myself to care.
As I recall I said to the LWNJ's hey let us go and travel on. Welp they said "no" let us stay here and take everything over....
Well...Hells Bells.....Eons later the tigers still protect their desert a/o as the rest that left and slowly destroyed the new surroundings....
So who was right and who is left?
Only a Bull Elephant (Whales), Hippo's and perhaps some joyful birds of no identity can answer that one.....
So shut moth you Long Tongued Giraffe...(keep)...trying though...
Be great Boozzzzzzzzzzzzzz(yawn)
Sentiment: Strong Buy
Agree, where did the article mention ACTC? Nowhere, that's where.
The article is real, recent and somewhat interesting. And yet I'll give you a "thumbs down" for choosing a misleading title that is nothing more than a conjecture.
* Severely ill may get access to some drugs years earlier
* Government hopes move will encourage pharmaceutical R&D
* Industry welcomes new scheme, concerned about funding
By Ben Hirschler
LONDON, March 14 (Reuters) - Britain is to accelerate access to ground-breaking drugs for serious conditions under a new early-access plan that the government hopes will benefit both patients and pharmaceutical companies.
The initiative, which has similarities with a U.S. scheme that has speeded the development of so-called "breakthrough" medicines, follows criticism that Britain's state-run healthcare system is too slow to adopt new medical treatments.
The Early Access to Medicines (Frankfurt: MZN.F - news) scheme, which was unveiled on Friday, will mean that patients with life-threatening and debilitating diseases may get access to novel medicines months or even years before they are officially licensed for sale.
Doctors will be able to prescribe promising new drugs as soon as the Medicines and Healthcare Products Regulatory Agency - the country's drugs watchdog - signals that the benefits outweigh the risks, following an initial scientific assessment.
The programme will be funded by drug companies. That is a bonus for the country's National Health Service, will which not bear any extra costs, but it is a bone of contention for the industry, even though companies overall applauded the plan.
Health minister Jeremy Hunt said the scheme would help make Britain a leading location for life sciences and drug development, and should create more jobs by encouraging firms to carry out more work in the country.
Pharma has traditionally been a key plank of the British economy, thanks to the presence of local groups such as GlaxoSmithKline (Other OTC: GLAXF - news) and AstraZeneca (NYSE: AZN - news) , and the presence of laboratories operated by several international players.
But recent cutbacks, including Pfizer (NYSE: PFE - news) 's decision three years ago to close its large R&D site in Sandwich, southern England, have dealt a blow to the sector and worried the government. That prompted a pledge by Prime Minister David Cameron in 2011 to improve early access to key new drugs.
The new scheme will be launched in April. Medicines deemed suitable for inclusion will be given a Promising Innovative Medicine designation, which could occur several years before licensing.
Although companies will have to fund early access out of their own pockets, they will gain valuable experience about drug use and be able to build up awareness of new medicines among prescribing doctors.
The Association of the British Pharmaceutical Industry welcomed the initiative. However, trade body said the lack of central funding was a concern and it asked that the scheme be reviewed after the first year to look at funding options.
(Reporting by Ben Hirschler. Editing by Jane Merriman)
edhelms35 • Jun 20, 2012 2:49 PM Flag
dont know who your broker is tons of fslr available to short...i am maxed out all in short at 15.49 avg cost...50000 shares....think i bag another 1/2 million dollars easy
edhelms35 • Jun 20, 2012 3:24 PM
you have no idea what you are doing...do you????
Dude....Just open your blind eyes and perceive how many orphans from china will be helpt on this....Dude....are YOU BLIND?